🇺🇸 Rocuronium Injection in United States

8 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Acute Kidney Injury — 1 report (12.5%)
  2. Anuria — 1 report (12.5%)
  3. Atrioventricular Block — 1 report (12.5%)
  4. Delayed Recovery From Anaesthesia — 1 report (12.5%)
  5. Pruritus — 1 report (12.5%)
  6. Pulmonary Function Test Decreased — 1 report (12.5%)
  7. Respiratory Depression — 1 report (12.5%)
  8. Therapy Cessation — 1 report (12.5%)

Source database →

Rocuronium Injection in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Rocuronium Injection approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Rocuronium Injection in United States?

Tang-Du Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.